217 related articles for article (PubMed ID: 1586374)
21. Evaluation of the pharmacokinetics and absolute bioavailability of three isosorbide-5-mononitrate preparations in healthy volunteers.
Hutt V; Bonn R; Fritschi E; Jaeger H
Arzneimittelforschung; 1995 Feb; 45(2):142-5. PubMed ID: 7710435
[TBL] [Abstract][Full Text] [Related]
22. Relationship between the pharmacodynamics and pharmacokinetics of two oral sustained-release formulations of isosorbide dinitrate in normal man.
Johnson KI; Gladigau V; Schnelle K
Arzneimittelforschung; 1981; 31(6):1026-9. PubMed ID: 7196234
[TBL] [Abstract][Full Text] [Related]
23. Isosorbide dinitrate disposition in the rat: metabolite pharmacokinetics and interactions.
Morrison RA; Fung HL
J Pharmacol Exp Ther; 1984 Oct; 231(1):124-30. PubMed ID: 6491969
[TBL] [Abstract][Full Text] [Related]
24. A novel transdermal patch incorporating isosorbide dinitrate with bisoprolol: in vitro and in vivo characterization.
Zhao JH; Fu JH; Wang SM; Su CH; Shan Y; Kong SJ; Wang Y; Lu WL; Zhang H; Zhang S; Li L; Zhang EH; Wang L; Pei QL; Wang JC; Zhang X; Zhang Q
Int J Pharm; 2007 Jun; 337(1-2):88-101. PubMed ID: 17267147
[TBL] [Abstract][Full Text] [Related]
25. [Dose-dependent serum concentration of ISDN and its metabolites following administration of ISDN-retard. Studies under steady-state conditions].
Loew D; Deuster U; Burkhardt H; Rietbrock N
Dtsch Med Wochenschr; 1986 Nov; 111(48):1834-7. PubMed ID: 3536397
[TBL] [Abstract][Full Text] [Related]
26. [Study of the bioequivalence of a new isosorbide dinitrate tablet formulation compared with the standard preparation].
Metzner JE; Buchberger D; Häring N; Läuter J
Arzneimittelforschung; 1997 Jun; 47(6):719-26. PubMed ID: 9281301
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of isosorbide-5-mononitrate after oral administration of an extended-release mononitrate formulation versus a standard dinitrate formulation.
Kosoglou T; Patrick JE; Cohen A; Radwanski E; Christopher D; Affrime MB
Clin Ther; 1995; 17(2):241-51. PubMed ID: 7614524
[TBL] [Abstract][Full Text] [Related]
28. Bioavailability of isosorbide dinitrate and its two mononitrate metabolites from sustained-release formulations.
Chasseaud LF; Doyle E; Taylor T; Darragh A; Lambe RF
Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):514-8. PubMed ID: 6642789
[TBL] [Abstract][Full Text] [Related]
29. [Biological availability and pharmacodynamics following single oral administration or three different sustained-release isosorbide-5-mononitrate dosage forms].
Merz PG; Thürmann P; Harder S
Arzneimittelforschung; 1992 Jan; 42(1):21-4. PubMed ID: 1586375
[TBL] [Abstract][Full Text] [Related]
30. Contribution of isosorbide-5-mononitrate, a major metabolite of isosorbide dinitrate (ISDN), to the hemodynamic effect of ISDN administered orally in conscious dogs.
Kogi K; Satoh T
Jpn J Pharmacol; 1987 Jul; 44(3):249-57. PubMed ID: 3656782
[TBL] [Abstract][Full Text] [Related]
31. Comparative pharmacokinetics of isosorbide nitrates after repeated doses of sustained release isosorbide dinitrate.
Laufen H; Leitold M; Wildfeuer A
Arzneimittelforschung; 1988 Sep; 38(9):1336-41. PubMed ID: 3223973
[TBL] [Abstract][Full Text] [Related]
32. Hemodynamic effects of oral isosorbide-5-mononitrate and dinitrate in ischemic heart failure.
Rabinowitz B; Hod H; Chouraqui P; Rath S; Agranat O; Neufeld HN
Clin Cardiol; 1987 Oct; 10(10):603-8. PubMed ID: 3665218
[TBL] [Abstract][Full Text] [Related]
33. Bioavailability of isosorbide dinitrate from an oral therapeutic system and from tablet Sorbonit Prolongatum 20,0 in human volunteers.
Sawicki W; Deptulski T; Janicki S
Pharmazie; 1989 Apr; 44(4):280-1. PubMed ID: 2772003
[TBL] [Abstract][Full Text] [Related]
34. Effects of an oral dose of isosorbide dinitrate on platelet function and fibrinolysis in healthy volunteers.
Wallén NH; Larsson PT; Bröijersén A; Andersson A; Hjemdahl P
Br J Clin Pharmacol; 1993 Feb; 35(2):143-51. PubMed ID: 8443032
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of three organic nitrates in Chinese healthy male volunteers.
Chen J; Jiang XG; Cai L; Lu W; Gao KP; Shi ZQ; Zhang QZ
Arzneimittelforschung; 2004; 54(4):203-6. PubMed ID: 15146932
[TBL] [Abstract][Full Text] [Related]
36. Influence of electric foot shock on pharmacokinetics of isosorbide dinitrate orally administered to rats.
Gomita Y; Furuno K; Araki Y
Jpn J Pharmacol; 1989 Feb; 49(2):297-9. PubMed ID: 2733266
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of intravenous isosorbide-dinitrate.
Platzer R; Reutemann G; Galeazzi RL
J Pharmacokinet Biopharm; 1982 Dec; 10(6):575-86. PubMed ID: 7182455
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of isosorbide dinitrate, isosorbide-2-nitrate and isosorbide-5-nitrate in renal insufficiency after repeated oral dosage.
Evers J; Bonn R; Boertz A; Cawello W; Dickmans HA; Weiss M
Klin Wochenschr; 1989 Mar; 67(6):342-8. PubMed ID: 2709744
[TBL] [Abstract][Full Text] [Related]
39. [Plasma levels of isosorbide dinitrate and its metabolites during intravenous infusion in surgical patients--effect of preoperative administration of isosorbide dinitrate].
Murakawa T; Hashimoto Y; Sato T; Takagi H; Kushikata T; Araki I; Kou H; Kimura F; Matsuki A
Masui; 1993 Feb; 42(2):225-32. PubMed ID: 8437354
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of isosorbide dinitrate in healthy volunteers after 24-hour intravenous infusion.
Bergami A; Bernasconi R; Caccia S; Leopaldi D; Mizrahi J; Sardina M; Urso R; Warrington SJ; Latini R
J Clin Pharmacol; 1997 Sep; 37(9):828-33. PubMed ID: 9549637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
